MA16.06 Real-world Survival with CRT+durvalumab for Unresectable, Stage III NSCLC in Canada: the RELEVANCE Study
Authors:
- P. Wheatley-PricePWP. Wheatley-Price
- V. NavaniVNV. Navani
- A. PabaniAPA. Pabani
- B. RoutyBRB. Routy
- S. SnowSSS. Snow
- M.-H. DenaultMDM.-H. Denault
- Y. KimYKY. Kim
- I. SyedISI. Syed
- N. DevostNDN. Devost
- D. HuiDHD. Hui
- P. AroraPAP. Arora
- R. VelummailumRVR. Velummailum
- 31 October 2023
- journal article
- abstracts
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 18 (11) , S159